No Data
No Data
shanghai kinetic medical (300326.SZ): Currently there are no similar allogeneic bone-related products.
Shanghai Kinetic Medical (300326.SZ) stated on the investor interaction platform on September 12 that the company currently does not have related products made from the same heterologous bone. The company's main implant products include spinal internal fixation products, bone cement, and vertebral fusion devices. The main raw materials for spinal internal fixation products are pure titanium or titanium alloy, the main component of bone cement is polymethyl methacrylate, and the main material for vertebral fusion devices is polyetheretherketone copper.
Kelly Thai: 2024 Semi-Annual Report
Kelly Tai: 2024 Semi-Annual Report Summary
Shanghai Kinetic Medical (300326.SZ): Net income in the first half of the year was 30.238 million yuan, a year-on-year decrease of 73.64%.
Gelonghui, August 27th. Shanghai Kinetic Medical (300326.SZ) released its 2024 interim report, with a revenue of 0.476 billion yuan during the reporting period, a year-on-year decrease of 8.96%; a net income attributable to shareholders of the listed company of 30.238 million yuan, a year-on-year decrease of 73.64%; a net income attributable to shareholders of the listed company after deducting non-recurring gains and losses of 24.9249 million yuan, a year-on-year decrease of 64.08%; and a basic earnings per share of 0.0422 yuan/share.
Shanghai Kinetic Medical (300326.SZ) announced its performance for the first half of the year, with a net income of 30.238 million yuan, a year-on-year decrease of 73.64%.
Shanghai Kinetic Medical (300326.SZ) released its 2024 semi-annual report, with a revenue of 0.476 billion yuan, an increase of...
Shanghai Kinetic Medical (300326.SZ): Annual equity distribution of 10 shares, 0.6 yuan per share for 2023. Ex-dividend date is July 16th.
On July 8th, Gelunhui reported that Shanghai Kinetic Medical (300326.SZ) announced the equity distribution plan for the year 2023: based on the total share capital of 717,012,682 shares excluding the repurchased 13,651 shares, the company will distribute 0.6 yuan per 10 shares to all shareholders. The equity distribution record date is July 15, 2024, and the ex-dividend date is July 16, 2024.
No Data
No Data